Publications by authors named "Emma Duffield"

Claim this Profile
A
Adult pain scores in the emergency department: a scoping review protocol.
Emma Duffield, Liza Keating, Sarah Wilson, Amelia Hollywood

BMJ Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of 2 dosing regimens of fostamatinib in patients with rheumatoid arthritis with an inadequate response to a tumor necrosis factor-α antagonist.
Mark C Genovese, Désirée M van der Heijde, Edward C Keystone, Alberto J Spindler, Claude Benhamou, Emma L Duffield

J Rheumatol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase III, randomized, open-label, first-line study in Asia of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer: evaluation of patients recruited from mainland China.
Yi-Long Wu, Da-Tong Chu, Baohui Han, Xuyi Liu, Li Zhang, Emma Duffield

Asia Pac J Clin Oncol· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidermal growth factor receptor mutation status in circulating free DNA in serum: from IPASS, a phase III study of gefitinib or carboplatin/paclitaxel in non-small cell lung cancer.
Koichi Goto, Yukito Ichinose, Yuichiro Ohe, Nobuyuki Yamamoto, Shunichi Negoro, Emma Duffield

J Thorac Oncol· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality-of-life in a randomized phase III first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients from Asia with advanced NSCLC (IPASS).
Sumitra Thongprasert, Emma Duffield, Nagahiro Saijo, Yi-Long Wu, James Chih-Hsin Yang

J Thorac Oncol· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non-small-cell lung cancer in Asia (IPASS).
Masahiro Fukuoka, Yi-Long Wu, Sumitra Thongprasert, Patrapim Sunpaweravong, Swan-Swan Leong, Emma L Duffield

J Clin Oncol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma.
Tony S Mok, Yi-Long Wu, Sumitra Thongprasert, Chih-Hsin Yang, Da-Tong Chu, Emma L Duffield

N Engl J Med· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Randomized phase II study of gefitinib compared with placebo in chemotherapy-naive patients with advanced non-small-cell lung cancer and poor performance status.
Glenwood Goss, David Ferry, Rafal Wierzbicki, Scott A Laurie, Joyce Thompson, Emma Duffield

J Clin Oncol· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of rosuvastatin and atorvastatin when force-titrated in patients with primary hypercholesterolemia: results from the ECLIPSE study.
Ole Faergeman, Laurie Hill, Eberhard Windler, Olov Wiklund, Roland Asmar, Emma Duffield

Cardiology· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II study.
Lucio Crinò, Federico Cappuzzo, Petr Zatloukal, Martin Reck, Milos Pesek, Emma L Duffield

J Clin Oncol· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of delay in cryo-fixation on biomarkers of Src tyrosine kinase activity in human breast and bladder cancers.
Rob J Jones, Tamsin Boyce, Michael Fennell, Vivien Jacobs, Francesco Pinto, Emma Duffield

Cancer Chemother Pharmacol· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rosuvastatin 40 mg alone or in combination with ezetimibe in patients at high risk of cardiovascular disease (results from the EXPLORER study).
Christie M Ballantyne, Robert Weiss, Tiziano Moccetti, Anja Vogt, Bernd Eber, Emma Duffield

Am J Cardiol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis